Creekmur Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$461K Sell
1,635
-369
-18% -$107K 0.08% 133
2025
Q2
$560K Buy
2,004
+184
+10% +$52.1K 0.1% 123
2025
Q1
$567K Buy
1,820
+762
+72% +$225K 0.12% 106
2024
Q4
$276K Sell
1,058
-10
-0.9% -$2.97K 0.06% 109
2024
Q3
$344K Sell
1,068
-1
-0.1% -$327 0.08% 91
2024
Q2
$334K Buy
1,069
+18
+2% +$5.29K 0.09% 91
2024
Q1
$299K Buy
1,051
+2
+0.2% +$585 0.1% 89
2023
Q4
$302K Buy
+1,049
New +$286K 0.09% 105

Other funds holding AMGN

Creekmur Asset Management's AMGN Position: Q3 2025 in Review

Creekmur Asset Management reduced its Amgen (AMGN) stake by 18% in Q3 2025, selling an estimated $107K and leaving 1,635 shares worth $461K. The position accounts for 0.08% of the portfolio, ranked #133.

Creekmur Asset Management first reported a position in AMGN in Q4 2023 and has held it in 8 quarters since. The position peaked at $567K in Q1 2025. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Creekmur Asset Management held 1,635 shares of Amgen worth $461K as of Q3 2025.
  • Creekmur Asset Management sold 369 Amgen shares in Q3 2025, an estimated $107K.
  • Amgen made up 0.08% of Creekmur Asset Management's portfolio in Q3 2025, its #133 holding.
  • Creekmur Asset Management first reported a position in Amgen in Q4 2023 and has held it in 8 quarters since.
  • Creekmur Asset Management's Amgen position peaked at $567K in Q1 2025.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Creekmur Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.